Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
vTv Therapeutics Inc. (VTVT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 8-K Quarterly results
Docs: "vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate Update"
07/20/2023 8-K Quarterly results
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/11/2023 8-K Quarterly results
Docs: "vTv Therapeutics Announces 2023 First Quarter Financial Results and Provides Corporate Update"
03/06/2023 8-K Quarterly results
Docs: "Therapeutics Announces 2022 Fourth Quarter and Full Year Financial Results and Provides Corporate Update"
02/01/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Elizabeth Keiley Selected as Executive Vice President and General Counsel of vTv Therapeutics HIGH POINT, N.C., February 1, 2023 -- vTv Therapeutics Inc. , a clinical stage biopharmaceutical company focused on the development of orally administered treatments for type 1 diabetes , today announced the appointment of Elizabeth Keiley as Executive Vice President and General Counsel, effective immediately. “We welcome Betzy to vTv. Her years of legal expertise and deep experience in life sciences will be valuable to the vTv team,” said Paul Sekhri, President and Chief Executive Officer of vTv Therapeutics. “Her decades of experience in both private practice and corporate settings make her an ideal fit for this position. I am confident that we will benefit from her contributions and look forwar..."
01/06/2023 8-K Investor presentation
Docs: "THE STATEMENTS MADE IN THIS PRESENTATION MAY INCLUDE FORWARD"
12/23/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/13/2022 8-K Quarterly results
11/10/2022 8-K Quarterly results
Docs: "Agreements with CinRx Pharma and"
08/15/2022 8-K Quarterly results
08/15/2022 8-K Quarterly results
07/27/2022 8-K Quarterly results
07/25/2022 8-K Quarterly results
07/15/2022 8-K Quarterly results
06/03/2022 8-K Quarterly results
06/01/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
04/15/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/29/2022 8-K Quarterly results
Docs: "vTv Therapeutics Announces 2021 fourth Quarter and Full Year Financial Results and Provides Corporate Update"
03/03/2022 8-K Quarterly results
02/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
12/06/2021 8-K Quarterly results
12/02/2021 8-K Quarterly results
11/09/2021 8-K Quarterly results
Docs: "vTv Therapeutics Announces 2021 Third Quarter Financial Results and Provides Corporate Update"
10/20/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "RETIREMENT AGREEMENT AND GENERAL RELEASE",
"EMPLOYMENT AGREEMENT",
"NONQUALIFIED OPTION AWARD AGREEMENT",
"Forward-Looking Statements This release contains forward-looking statements, which involve risks and uncertainties. These forward-looking statements can be identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. All statements other than statements of historical facts contained in this release, including statements regarding the timing of our clinical trials, our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, objectives of management and expected market growth are forward-looking stateme..."
08/04/2021 8-K Quarterly results
Docs: "vTv Therapeutics Announces 2021 Second Quarter Financial Results and Provides Corporate Update"
06/25/2021 8-K Quarterly results
05/05/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
01/21/2021 8-K Entry into a Material Definitive Agreement
01/14/2021 8-K Quarterly results
12/30/2020 8-K Resignation/termination of a director
Docs: "Executive Chairman Agreement, by and between vTv Therapeutics Inc. and Robin E. Abrams"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy